Literature DB >> 22842173

The relevance of "Nonsmoking-associated lung cancer" in India: a single-centre experience.

A Krishnamurthy1, R Vijayalakshmi, V Gadigi, R Ranganathan, T G Sagar.   

Abstract

BACKGROUND: Lung cancer remains a major cause of morbidity and mortality worldwide, accounting for more deaths than any other cancer cause. AIM: The aim of this study was to analyze the clinical profile and the epidemiological trends in lung cancer patients from a single centre with an emphasis on the smoking practices.
MATERIALS AND METHODS: This is a retrospective analysis of prospectively collected data of 258 consecutive hospital in-patients with a proven diagnosis of lung cancer at a tertiary care oncology centre between 2003 and 2007.
RESULTS: The median age of patients in our study was 56 years; the male to female ratio was approximately 3.5:1. Non-small-cell lung cancer (NSCLC) was the predominant histology in 224 patients; the histology in the remaining 34 patients was small-cell carcinoma. Within NSCLC, the most common histology was adenocarcinoma followed by squamous cell carcinoma. One hundred and two patients were never-smokers as compared to 156 patients who were ever-smokers. Among the smokers, the majority of them were found to be cigarette smokers compared to 28.2% bidi smokers. There was a very significant correlation found with adenocarcinoma among nonsmokers, and with squamous cell carcinoma among the smokers compared to non-smokers.
CONCLUSIONS: Our study suggests that the epidemiology of lung cancer in India is possibly changing, with close to 40% of our lung cancer patients being nonsmokers. More importantly, our study reflects the global trend of rise in adenocarcinoma histology. These observations need to be substantiated in similar studies of larger magnitude, preferably population-based.

Entities:  

Mesh:

Year:  2012        PMID: 22842173     DOI: 10.4103/0019-509X.98928

Source DB:  PubMed          Journal:  Indian J Cancer        ISSN: 0019-509X            Impact factor:   1.224


  14 in total

1.  A meta-analysis of the relationship between glutathione S-transferase T1 null/presence gene polymorphism and the risk of lung cancer including 31802 subjects.

Authors:  Hua-Fu Zhou; Xu Feng; Bao-Shi Zheng; Jun Qian; Wei He
Journal:  Mol Biol Rep       Date:  2013-09-26       Impact factor: 2.316

2.  Association of glutathione S-transferase P1 gene polymorphism with the histological types of lung cancer: a meta-analysis.

Authors:  Xu Feng; Hua-Fu Zhou; Bao-Shi Zheng; Jun-Jie Shi; Cheng Luo; Jia-Jin Qin
Journal:  Mol Biol Rep       Date:  2012-11-27       Impact factor: 2.316

3.  EGFR mutations in Indian lung cancer patients: clinical correlation and outcome to EGFR targeted therapy.

Authors:  Vanita Noronha; Kumar Prabhash; Abhishek Thavamani; Anuradha Chougule; Nilendu Purandare; Amit Joshi; Rashmi Sharma; Saral Desai; Nirmala Jambekar; Amit Dutt; Rita Mulherkar
Journal:  PLoS One       Date:  2013-04-19       Impact factor: 3.240

4.  Clinical and epidemiological study of EGFR mutations and EML4-ALK fusion genes among Indian patients with adenocarcinoma of the lung.

Authors:  Dc Doval; K Prabhash; S Patil; H Chaturvedi; C Goswami; Ak Vaid; S Desai; S Dutt; Vh Veldore; N Jambhekar; A Mehta; D Hazarika; S Azam; S Gawande; S Gupta
Journal:  Onco Targets Ther       Date:  2015-01-05       Impact factor: 4.147

Review 5.  Lung cancer in the Indian subcontinent.

Authors:  Vanita Noronha; Rakesh Pinninti; Vijay M Patil; Amit Joshi; Kumar Prabhash
Journal:  South Asian J Cancer       Date:  2016 Jul-Sep

6.  Clinicopathological features and outcomes in advanced nonsmall cell lung cancer with tailored therapy.

Authors:  Stalin Bala; Sadashivudu Gundeti; Vijay Gandhi Linga; Lakshmi Srinivas Maddali; Raghunadha Rao Digumarti; Shantveer G Uppin
Journal:  Indian J Med Paediatr Oncol       Date:  2016 Oct-Dec

7.  Clinical profile of lung cancer in North India: A 10-year analysis of 1862 patients from a tertiary care center.

Authors:  Anant Mohan; Avneet Garg; Aditi Gupta; Satyaranjan Sahu; Chandrashekhar Choudhari; Vishal Vashistha; Ashraf Ansari; Rambha Pandey; Ashu Seith Bhalla; Karan Madan; Vijay Hadda; Hariharan Iyer; Deepali Jain; Rakesh Kumar; Saurabh Mittal; Pawan Tiwari; Ravindra M Pandey; Randeep Guleria
Journal:  Lung India       Date:  2020 May-Jun

8.  A study of therapy targeted EGFR/ALK mutations in Indian patients with lung adenocarcinoma: A clinical and epidemiological study.

Authors:  Vandana Rana; Praveer Ranjan; Rajat Jagani; K R Rathi; Dharmesh Kumar; Anurag Khera
Journal:  Med J Armed Forces India       Date:  2017-11-28

9.  Individual and combined effects of GSTM1, GSTT1, and GSTP1 polymorphisms on lung cancer risk: A meta-analysis and re-analysis of systematic meta-analyses.

Authors:  Wen-Ping Zhang; Chen Yang; Ling-Jun Xu; Wei Wang; Liang Song; Xiao-Feng He
Journal:  Medicine (Baltimore)       Date:  2021-07-02       Impact factor: 1.817

10.  Epidermal growth factor receptor mutation in lung adenocarcinoma in India: A single center study.

Authors:  Dinesh Chandra Doval; Saud Azam; Ullas Batra; Kumardeep Dutta Choudhury; Vineet Talwar; Sunil Kumar Gupta; Anurag Mehta
Journal:  J Carcinog       Date:  2013-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.